Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| Hs 578T | Linsitinib | 10 | uM | 10 | 156.25 | 66.59 | 430.00 | 300.00 | 1.4333 | 1.3606 |
| Hs 578T | 17-AAG | 0.1 | uM | 10 | 156.25 | 66.59 | 63.00 | 300.00 | 0.2100 | -0.0252 |
| Hs 578T | Lapatinib | 0.01 | uM | 10 | 156.25 | 66.59 | 374.00 | 300.00 | 1.2467 | 1.2137 |
| Hs 578T | 17-AAG | 0.031623 | uM | 10 | 156.25 | 66.59 | 62.00 | 300.00 | 0.2067 | -0.0324 |
| Hs 578T | Lapatinib | 0.1 | uM | 10 | 156.25 | 66.59 | 402.00 | 300.00 | 1.3400 | 1.2886 |
| Hs 578T | Lapatinib | 0.031623 | uM | 10 | 156.25 | 66.59 | 243.00 | 300.00 | 0.8100 | 0.8151 |
| Hs 578T | Linsitinib | 3.1623 | uM | 10 | 156.25 | 66.59 | 320.00 | 300.00 | 1.0667 | 1.0603 |
| Hs 578T | 0 | uM | 10 | 156.25 | 66.59 | 322.00 | 300.00 | 1.0733 | 1.0663 | |
| Hs 578T | Erlotinib | 0.1 | uM | 10 | 156.25 | 66.59 | 348.00 | 300.00 | 1.1600 | 1.1415 |
| Hs 578T | Linsitinib | 0.31623 | uM | 10 | 156.25 | 66.59 | 307.00 | 300.00 | 1.0233 | 1.0214 |
| Hs 578T | Linsitinib | 0.1 | uM | 10 | 156.25 | 66.59 | 229.00 | 300.00 | 0.7633 | 0.7661 |
| Hs 578T | Erlotinib | 1 | uM | 10 | 156.25 | 66.59 | 423.00 | 300.00 | 1.4100 | 1.3429 |
| Hs 578T | Linsitinib | 19.9526 | uM | 10 | 156.25 | 66.59 | 244.00 | 300.00 | 0.8133 | 0.8185 |
| Hs 578T | Erlotinib | 0.031623 | uM | 10 | 156.25 | 66.59 | 402.00 | 300.00 | 1.3400 | 1.2886 |
| Hs 578T | 0 | uM | 10 | 156.25 | 66.59 | 278.00 | 300.00 | 0.9267 | 0.9311 | |
| Hs 578T | 17-AAG | 3.1623 | uM | 10 | 156.25 | 66.59 | 73.00 | 300.00 | 0.2433 | 0.0432 |
| Hs 578T | 0 | uM | 10 | 156.25 | 66.59 | 298.00 | 300.00 | 0.9933 | 0.9939 | |
| Hs 578T | 0 | uM | 10 | 156.25 | 66.59 | 297.00 | 300.00 | 0.9900 | 0.9908 | |
| Hs 578T | 17-AAG | 10 | uM | 10 | 156.25 | 66.59 | 42.00 | 300.00 | 0.1400 | -0.1912 |
| Hs 578T | 17-AAG | 0.0016596 | uM | 10 | 156.25 | 66.59 | 311.00 | 300.00 | 1.0367 | 1.0334 |
| Hs 578T | Lapatinib | 0.0033113 | uM | 10 | 156.25 | 66.59 | 425.00 | 300.00 | 1.4167 | 1.3479 |
| Hs 578T | Erlotinib | 0.01 | uM | 10 | 156.25 | 66.59 | 294.00 | 300.00 | 0.9800 | 0.9815 |
| Hs 578T | 0 | uM | 10 | 156.25 | 66.59 | 379.00 | 300.00 | 1.2633 | 1.2273 | |
| Hs 578T | Erlotinib | 3.1623 | uM | 10 | 156.25 | 66.59 | 426.00 | 300.00 | 1.4200 | 1.3505 |
| Hs 578T | Lapatinib | 0.0016596 | uM | 10 | 156.25 | 66.59 | 397.00 | 300.00 | 1.3233 | 1.2754 |